Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases

Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 casesHydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases, Published online: 12 November 2018; doi:10.1038/s41408-018-0151-yHydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases

Source: Blood Cancer Journal - November 12, 2018 Category: Hematology Authors: Valerio De Stefano Elena Rossi Alessandra Carobbio Arianna Ghirardi Silvia Betti Guido Finazzi Alessandro M. Vannucchi Tiziano Barbui Source Type: research